TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: MDS UPDRS Motor Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful dural puncture on the first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CAPS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean heart rate variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients randomized who receive the intervention
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from baseline distance walked in 6 minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline time needed to complete Timed-Up-and-Go test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline Isokinetic strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial pressure waveform changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 3-year relapse free survival
Endpoint domain: Mortality/survival
Primary endpoint: Edinburgh feeding evaluation in dementia (EdFED) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Katz Daily Life Activities Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in CFGS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in main daily problem
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in function score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time to Sustained Clinical Resolution of Symptoms of COVID-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients maintaining EASI ≤ 7 OR NRS ≤ 4 OR DLQI ≤ 5
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean percent change from baseline in Atopic Dermatitis Control Tools (ADCT) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent change from baseline in Recap of atopic eczema (RECAP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Nerve Conduction Study
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Estimation of Albumin & Globulin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitive responsiveness scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite CR rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Needle Placement Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-infinity curve (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Oxygenation Index (OI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Voice Handicap Index 10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Vocal Fatigue Index (VFI) factor 1 and 2
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: 1-year recurrence-free survival (RFS)
Endpoint domain: Mortality/survival
Primary endpoint: Change from baseline Conditioned Pain Modulation (CPM) in the lower back
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline Temporal Sumation of Pain (TSP) in the lower back
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline Pressure pain threshold (PPT) in the lower back
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in pressure pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in cold detection threshold and heat pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in rating of mechanical activation of cutaneous nociceptive afferents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in auditory detection threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of pain due to knee OA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of GDMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence, Type, and Severity of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Treatment-emergent Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom Response Rate at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline vital sign measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from baseline safety laboratory measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality of COVID-19 patients with adrenal insufficiency
Endpoint domain: Mortality/survival
Primary endpoint: Microbiome alpha diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-month major ischemic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adherence Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Insight and Treatment Attitude Questionnaire (ITAQ)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tic Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distress Levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: wellbeing of the patients
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Functional mobility of the patients
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Self-reports of alcohol, substance use and gambling with the Time-Line Follow-Back (TLFB) in the last 90 days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Canadian Problem Gambling Severity Index (PGSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Severity of dependence scale (SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement with right atrial pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of infective endocarditis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Olerud-Molander Ankle Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal dynamic strength of shoulder muscles post-supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aerobic fitness post-supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lean and fat mass post-supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eating Attitudes Test-40 score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of activated autoantigen-specific T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Counter Movement Jump performance (height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drop Jump performance (height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Squat Jump performance (height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Run-up right-foot take-off performance (height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Run-up left-foot take-off performance (height)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-meter sprint performance (time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usage of DCIT behavioral methods
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Binocular Distance Corrected Near Visual Acuity at 40 cm Under Photopic Conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular Distance Corrected Near Visual Acuity at 40 cm Under Mesopic Conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial skin pigment intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Energy delivery at 7th day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Protein delivery at 7th day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: knowledge learning outcome
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Technology Acceptance learning outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Reasoning Evaluation Simulation learning outcome
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: self-efficacy learning outcome
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in physical disability (FACT)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in physical disability (6MWT)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Clinical meaningful decrease in severity of GI-symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Post-operative impingement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hamilton Depression Scale (HAMD) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Depression Inventory (CDI) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysplastic changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in health literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pathological complete response (ypT0N0) and negative ctDNA status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 2-year complete response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cumulative bleeding incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C Reactive Protein (CRP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Neutrophil to Lymphocyte Ratio (NLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mother-Infant Attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-Confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Care Participation
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Obesity Status (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epileptic activity (IEDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma-total CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overall presence of malnutrition risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in CPR skills (acquisition)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in CPR skills retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thirst Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: JC viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Detection of immune responses against a JCV peptide library
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Severity score of pelvic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Situational Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of adverse events (AE) severity grade 2 or more
Endpoint domain: Adverse events/effects
Primary endpoint: Detection of lymph nodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Blood analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Somatic indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of rheumatic flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of rheumatic flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: How Satisfied the Participant Was With the Treatment as Measured by the tDCS Experience Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety of Home-based tDCS Treatment as Assessed by Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Total block application time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cognitive Functions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Neurological morbidity at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Overall change in nasal airway gene expression profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability in multiple sclerosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Retention of the implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Paroxysmal Atrial Fibrillation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptable error rate for BCC detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of practice scans needed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median time to assess OCT scans
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Replication efficiency of influenza virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Replication efficiency of coronavirus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Achieving Confirmed Complete Closure of StrataGraft Treatment Sites without Autograft
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of patients across all lines of therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Healthcare costs among patients with three lines of therapy or more
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Objective response rate (complete response/partial response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dynamic α-fetoprotein response (AFP-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of practitioners recruited to deliver GenPMTO
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of eligible caregivers who are offered GenPMTO who accept this offer (take-up of services)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention / drop-out rates of caregivers receiving GenPMTO
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients enrolled in the clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of patients remaining in the clinical trial to completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Extent of Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sheehan Disability scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Language development discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of knee muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of LVRR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Biodex balance assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amino Acids concentration in cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Lactate concentration in cerebrospinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical status on day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson's disease sleep scale (PDSS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: polysomnography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine Diary
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bulls eye - activation in valued direction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the number of intratumoral CD8+ T-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time-averaged mean velocity of the superior mesenteric artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Superior Vena Cava flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: estimated pulmonary artery pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: score for remembering the drug name
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: score for remembering the drug symbol
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of participants who completed the intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of eligible participants who consented to be in study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adverse events occurring within one day of TEGSEDI administration
Endpoint domain: Adverse events/effects
Primary endpoint: Agreement between automatic grading and clinical grading (VH test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between automatic grading and clinical grading (gonioscopy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survivorship of SYMBOL orthopaedic components
Endpoint domain: Mortality/survival
Primary endpoint: Immunization coverage rate for human papillomavirus vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cell growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of the Maximum Observed Post-dose Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Post-dose Concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to tolerate distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pediatric Reach Test (Pediatric Functional Reach Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Health-Related Quality of Life (HRQoL) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Detection of bleeding risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in EGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in IGF-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in PDGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in TGF-beta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Changes in VEGF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes